Skip to Main Content

Paper Details

Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases.
Cancer Biol Med
13
2021
Author NameAffiliation
Xue WuTranslational Medicine Research Institute, Geneseeq Technology Inc.
Yang ShaoTranslational Medicine Research Institute, Geneseeq Technology Inc.
Yang ShaoSchool of Public Health, Nanjing Medical University
  • 1 - 3

Datasets

Release 1.2